{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:07:21Z","timestamp":1753880841197,"version":"3.41.2"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2021,8,18]]},"abstract":"<jats:p>External quality assessment (EQA) is a key instrument for achieving harmonization, and thus a high quality, of diagnostic procedures. As reliable test results are crucial for accurate assessment of SARS-CoV-2 infection prevalence, vaccine response, and immunity, and thus for successful management of the ongoing COVID-19 pandemic, the Reference Institute for Bioanalytics (RfB) was the first EQA provider to offer an open scheme for anti-SARS-CoV-2 antibody detection.<\/jats:p>","DOI":"10.1128\/jcm.00559-21","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T15:47:58Z","timestamp":1625068078000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":7,"title":["Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection"],"prefix":"10.1128","volume":"59","author":[{"given":"Volker","family":"Ast","sequence":"first","affiliation":[{"name":"Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Costina","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romy","family":"Eichner","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bode","sequence":"additional","affiliation":[{"name":"Reference-Institute for Bioanalytics, German Society for Clinical Chemistry and Laboratory Medicine (DGKL), Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihem","family":"Aida","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina","family":"Gerhards","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot","family":"Thiaucourt","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Dobler","sequence":"additional","affiliation":[{"name":"Bundeswehr Institute of Microbiology, Munich, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolf-Jochen","family":"Geilenkeuser","sequence":"additional","affiliation":[{"name":"Reference-Institute for Bioanalytics, German Society for Clinical Chemistry and Laboratory Medicine (DGKL), Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"W\u00f6lfel","sequence":"additional","affiliation":[{"name":"Bundeswehr Institute of Microbiology, Munich, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Neumaier","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8380-6581","authenticated-orcid":true,"given":"Verena","family":"Haselmann","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","unstructured":"U.S. Food & Drug Administration. Emergency use authorization. in vitro diagnostic products. https:\/\/www.fda.gov\/emergency-preparedness-and-response\/mcm-legal-regulatory-and-policy-framework\/emergency-use-authorization."},{"key":"e_1_3_3_3_2","unstructured":"European Commission. COVID-19 in vitro diagnostic devices and test methods database. https:\/\/covid-19-diagnostics.jrc.ec.europa.eu\/devices?manufacturer&text_name&marking&rapid_diag&format&target_type&field-1=Assay%20category&value-1=3&field-2=Assay%20category&value-2=4&search_method=OR#form_content."},{"key":"e_1_3_3_4_2","unstructured":"U.S. Food & Drug Administration. Insight into FDA\u2019s revised policy on antibody tests: prioritizing access and accuracy. https:\/\/www.fda.gov\/news-events\/fda-voices\/insight-fdas-revised-policy-antibody-tests-prioritizing-access-and-accuracy."},{"key":"e_1_3_3_5_2","unstructured":"U.S. Food & Drug Administration. EUA authorized serology test performance. https:\/\/www.fda.gov\/medical-devices\/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices\/eua-authorized-serology-test-performance."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.07.007"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.05.020"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00797-20"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention. Interim guidelines for COVID-19 antibody testing. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/resources\/antibody-tests-guidelines.html.","DOI":"10.46234\/ccdcw2020.085"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02148-20"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-1554"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2020.06.001"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2016-0081"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2011.168641"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.254482"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0877-0"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-1183"},{"key":"e_1_3_3_18_2","unstructured":"RfB. 2020. Surveys corona antibodies 2020. https:\/\/www.rfb.bio\/cgi\/surveys?searchType=rv_type&rv_type=CoVimm&analyte=all&year=2020."},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000926"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.16.2000421"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17124417"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0659-0"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.15927.1"},{"key":"e_1_3_3_24_2","unstructured":"FDA. Minimum performance requirements for COVID-19 test kits used for SARS-CoV-2 infection. https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2021\/03\/FDA-Memorandum-No.-2021-009.pdf."},{"key":"e_1_3_3_25_2","unstructured":"EU. Guidance - MDCG 2021-2. Guidance on state of the art of COVID-19 rapid antibody tests. https:\/\/ec.europa.eu\/health\/sites\/default\/files\/md_sector\/docs\/mdcg_2021-2_en.pdf."},{"key":"e_1_3_3_26_2","unstructured":"FDA. Letter of emergency use authorization for in vitro diagnostic SARS-CoV-2 antibody tests. https:\/\/www.fda.gov\/media\/137470\/download."},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1515\/dx-2020-0135"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76914-5"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4262"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa262"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa198"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26669"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02596-20"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30634-4"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.04.080"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1143"},{"key":"e_1_3_3_37_2","unstructured":"Roche. 2020. Roche. Elecsys Anti-SARS-CoV-2. https:\/\/diagnostics.roche.com\/us\/en\/products\/params\/elecsys-anti-sars-cov-2.html."},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.584251"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21336-8"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00559-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00559-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T12:55:39Z","timestamp":1646484939000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.00559-21"}},"subtitle":[],"editor":[{"given":"Yi-Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,8,18]]}},"alternative-id":["10.1128\/JCM.00559-21"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00559-21","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"type":"print","value":"0095-1137"},{"type":"electronic","value":"1098-660X"}],"subject":[],"published":{"date-parts":[[2021,8,18]]},"assertion":[{"value":"2021-03-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00559-21"}}